Diagnostic and Statistical Manual of Mental Disorders (DSM-5)5
|
Exposure to dopamine antagonist within 72 hours prior to symptom development
Hyperthermia (>100.4°F or >38°C on at least two occasions)
Generalized rigidity
Creatine kinase elevation (at least four times upper limit of normal)
Changes in mental status
Autonomic instability (tachycardia, diaphoresis, blood pressure elevation or fluctuation, urinary incontinence, pallor)
|
Presence of these cardinal features are suggestive of diagnosis |
Major:
Minor:
|
Presence of all three major, or two major and four minor features |
Caroff, Mann 1936 |
Major:
Treatment of neuroleptics within seven days of onset (2–4 weeks for depot)
Hyperthermia
Muscle rigidity
Exclusion of other drug-induced, systemic, or neuropsychiatric illnesses
Minor:
Change in mental status
Tachycardia, hypertension or hypotension, tachypnea or silorrhea
Tremors
Incontinence
Creatine phosphokinase elevation or myoglobinuria, leukocytosis, metabolic acidosis
|
Presence of all four major items and five minor features |